Business Strategies
RebrAIn Update: French AI Company Advances Precision Neurostimulation
David Caumartin, CEO of RebrAIn talked to MedTech Strategist about his company’s progress developing and commercializing a supervised artificial intelligence system that improves the precision of neurosurgery for movement disorders.
Read Article